Literature DB >> 1719801

Assessment of antigen damage in immunohistochemistry. The vimentin internal control.

H Battifora1.   

Abstract

Monitoring of the quality of antigen preservation and the uniformity of tissue fixation in paraffin-embedded, formaldehyde-fixed tissues is facilitated by the routine use of an antibody to an epitope of vimentin that is partially susceptible to formaldehyde fixation. Other diagnostically useful molecules often show fixation- or processing-induced alterations that parallel those of the vimentin epitope. Thus, the use of vimentin as an internal control, or reporter molecule, and its extrapolation to other antigens allow for better interpretation of results, improved selection of fields optimal for diagnostic immunohistochemistry, and more rational application of compensatory procedures, such as protease digestion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719801     DOI: 10.1093/ajcp/96.5.669

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  21 in total

1.  Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.

Authors:  C Christofer Juhlin; Inga-Lena Nilsson; Kenth Johansson; Felix Haglund; Andrea Villablanca; Anders Höög; Catharina Larsson
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

2.  Application of cryo-compatible antibodies to human placenta paraffin sections.

Authors:  Astrid Blaschitz; Martin Gauster; Gottfried Dohr
Journal:  Histochem Cell Biol       Date:  2008-06-18       Impact factor: 4.304

3.  Tissue preparation for immunocytochemistry.

Authors:  J H Williams; B L Mepham; D H Wright
Journal:  J Clin Pathol       Date:  1997-05       Impact factor: 3.411

Review 4.  Antigen retrieval, signal amplification and intensification in immunohistochemistry.

Authors:  M Werner; R Von Wasielewski; P Komminoth
Journal:  Histochem Cell Biol       Date:  1996-04       Impact factor: 4.304

5.  Antigen Masking During Fixation and Embedding, Dissected.

Authors:  Carla Rossana Scalia; Giovanna Boi; Maddalena Maria Bolognesi; Lorella Riva; Marco Manzoni; Linde DeSmedt; Francesca Maria Bosisio; Susanna Ronchi; Biagio Eugenio Leone; Giorgio Cattoretti
Journal:  J Histochem Cytochem       Date:  2016-10-23       Impact factor: 2.479

6.  Mechanical fractionation of tissues using microsecond-long HIFU pulses on a clinical MR-HIFU system.

Authors:  Avinash Eranki; Navid Farr; Ari Partanen; Karun V Sharma; Christopher T Rossi; Avi Z Rosenberg; AeRang Kim; Matthew Oetgen; Haydar Celik; David Woods; Pavel S Yarmolenko; Peter C W Kim; Bradford J Wood
Journal:  Int J Hyperthermia       Date:  2018-02-22       Impact factor: 3.914

7.  In vivo infiltration of mononuclear cells in squamous cell carcinoma of the head and neck correlates with the ability to expand tumour-infiltrating T cells in vitro and with the expression of MHC class I antigens on tumour cells.

Authors:  J Hald; N Rasmussen; M H Claesson
Journal:  Cancer Immunol Immunother       Date:  1994-12       Impact factor: 6.968

8.  Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR).

Authors:  M M Webber; D Bello-DeOcampo; S Quader; N D Deocampo; W S Metcalfe; R M Sharp
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

9.  Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonates.

Authors:  Laetitia Martinerie; Say Viengchareun; Anne-Lise Delezoide; Francis Jaubert; Martine Sinico; Sophie Prevot; Pascal Boileau; Geri Meduri; Marc Lombès
Journal:  Endocrinology       Date:  2009-05-28       Impact factor: 4.736

10.  Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer.

Authors:  Jenny Permuth-Wey; David Boulware; Nikola Valkov; Sandra Livingston; Santo Nicosia; Ji-Hyun Lee; Rebecca Sutphen; Joellen Schildkraut; Steven Narod; Alex Parker; Domenico Coppola; Thomas Sellers; Tuya Pal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.